A phase 1, open-label safety and immunogenicity study of an AS03-adjuvanted trivalent inactivated influenza vaccine in children aged 6 to 35 months

Background: There is a need for better vaccines and vaccine strategies to reduce the burden of influenza in very young children.   Methods: This phase 1, open-label study assessed the reactogenicity, safety, and immunogenicity of an inactivated trivalent influenza vaccine (TIV) containing low doses...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Carmona Martinez, Alfonso, Salamanca de la Cueva, Ignacio, Boutet, Philippe, Vanden Abeele, Carline, Smolenov, Igor, Devaster, Jeanne-Marie
Formato: Artigo
Idioma:Inglês
Publicado em: Landes Bioscience 2014
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4186022/
https://ncbi.nlm.nih.gov/pubmed/25424805
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.28743
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados